Zobrazeno 1 - 10
of 2 701
pro vyhledávání: ''
Autor:
Vieri Scotti, Beatrice Fantechi, Francesca Mazzoni, I. Stasi, Irene Pecora, Carmelo Tibaldi, Enrico Vasile, Chiara Caparello, Editta Baldini, Marianna Turrini, Lorenzo Antonuzzo, Francesca Federici, Andrea Camerini, Giulia Meoni, Daniele Pozzessere, Diana Giannarelli, Virginia Rossi, L.P. Ciccone
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 22:1278-1285
Background: In advanced non-small-cell lung cancer, without activating mutations and with PD-L1≥50%, Pembrolizumab monotherapy is the therapeutic standard in Europe. Objective: To evaluate retrospectively the safety and efficacy of this drug and to
Autor:
John B. A. G. Haanen, Maureen J.B. Aarts, Michel W.J.M. Wouters, Albert J. ten Tije, Astrid A M van der Veldt, Karijn P M Suijkerbuijk, Rozemarijn S. van Rijn, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Ellen Kapiteijn, Geke A. P. Hospers, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Gerard Vreugdenhil, Michiel C T van Zeijl, Jan-Willem B de Groot, Djura Piersma
Publikováno v:
International Journal of Cancer, 150(2), 317-326. Wiley-Liss Inc.
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800
International Journal of Cancer, 150(2), 317-326. Wiley
International Journal of Cancer, 150(2), 317-326. WILEY
International Journal of Cancer, 150, 2, pp. 317-326
International Journal of Cancer, 150, 317-326
van Zeijl, M C T, van den Eertwegh, A J M, Wouters, M W J M, de Wreede, L C, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, van der Hoeven, J J M & Haanen, J B A G 2022, ' Discontinuation of anti-PD-1 monotherapy in advanced melanoma—Outcomes of daily clinical practice ', International Journal of Cancer, vol. 150, no. 2, pp. 317-326 . https://doi.org/10.1002/ijc.33800
Contains fulltext : 287666.pdf (Publisher’s version ) (Open Access) There is no consensus on the optimal treatment duration of anti-PD-1 for advanced melanoma. The aim of our study was to gain insight into the outcomes of anti-PD-1 discontinuation,
Publikováno v:
Cancer Biomarkers. 32:559-567
BACKGROUND: CA125 level normalization at different chemotherapy cycles has been reported to be a prognosticator in advanced epithelial ovarian cancer. OBJECTIVE: In the present study, we investigated whether the time (in days) to CA125 normalization
Autor:
Mingxuan Zhu, Zhuokai Zhuang, Yumo Xie, Ziying Huang, Yaoyi Huang, Dingcheng Shen, Juan Li, Huichuan Yu, Yanxin Luo, Xiaolin Wang, Rongzhao He, Meijin Huang
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8924-8933 (2021)
Cancer Medicine
Cancer Medicine
Objective We conducted this multicenter cohort study to evaluate the current tumor‐node‐metastasis staging system and treatment modality by analyzing the survival outcomes of patient groups with stage III and IV colon cancer. Patients and Methods
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 74-85 (2022)
Cancer Medicine
Cancer Medicine
Objective This study was designed to establish and validate promising and reliable nomograms for predicting the survival of angiosarcoma (AS) patients. Methods The Surveillance, Epidemiology, and End Results database was queried to collect the clinic
Autor:
Wei Liu, Lisong Teng, Xiao Wang, Xiangyi Zheng, Jiazhu Sun, Liping Xie, Haixiang Shen, Jin Liu
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7492-7502 (2021)
Cancer Medicine
Cancer Medicine
Introduction Cytoreductive surgery is one of the recommended treatments for metastatic renal cell carcinoma, while the prognostic information of these patients treated with cytoreductive surgery is limited. In this study, we aimed to investigate the
Autor:
Jae Yong Park, Sook Kyung Do, Shin Yup Lee, Moon-June Cho, Jun-Sang Kim, Min Kyu Kang, Jin Eun Choi
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8071-8078 (2021)
Cancer Medicine
Cancer Medicine
Background To investigate the impact of programmed death‐ligand 1 (PD‐L1) polymorphisms on the prognosis of non‐small cell lung cancer (NSCLC) patients treated with curative radiotherapy. Methods Four single nucleotide polymorphisms (SNPs) (rs8
Autor:
Lixiao Liu, Wenfeng Li, Xuedan Du, Ye Zhao, Chengyang Zou, Jinduo Zhao, Xiao-Jian Yan, Heling Zhou
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 9097-9114 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 9097-9114 (2021)
Background Ovarian cancer (OC) is the most lethal gynecological malignancy. The objective of this study was to establish and validate an individual aging‐related gene signature and a clinical nomogram that can powerfully predict independently the o
Autor:
De Shen Wang, Long Bai, Han Zhou, Wan-Lan Huang, Ze-Yu Lin, Qin Chen, Yun-Le Wan, Yun-Xin Lu, Qi Meng, Chun-Ping Lin, Zhizhong Pan
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 8005-8019 (2021)
Cancer Medicine
Cancer Medicine
Background The prognostic value of lactate dehydrogenase (LDH) in colorectal cancer patients has remained inconsistent between nonmetastatic and metastatic settings. So far, very few studies have included LDH in the prognostic analysis of curative‐
Autor:
Linlin Ji, Xiao-Bei Mao, Mengxi Huang, Dan Xiang, Gongbo Fu, Siqi Sheng, Xiaoyuan Chu, Jiani Guo, Jialong Zhu, Shuai Hao, Yadi Huang, Zengjie Lei
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 23, Pp 8708-8719 (2021)
Cancer Medicine, Vol 10, Iss 23, Pp 8708-8719 (2021)
Background Some significant differences exist between the outcomes of left‐ and right‐sided colon cancer patients. The presence of nodal metastases is a critical prognostic factor, especially in the absence of distant metastasis. Our research stu